Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
About
2DS) Clinical features and risks Managing psychiatric disorders 22q11.2 deletion syndrome General prescribing principles
Abilify MyCite, adherence monitoring aid
Absolute risk of intracranial haemorrhage with SSRI with or without anticoagulant or NSAIDs
Acetaldehyde, metabolism of alcohol
acetylcholinesterase inhibitors (AChE-Is) Dementia with Lewy bodies Mechanism of action 630, Older patients and dementia Rare dementias associated with neurological conditions Vascular dementia Alzheimer's disease Management of behavioural and psychological symptoms of dementia Mild cognitive impairment Other dementias 647, ,649 Use in Parkinson's disease
Activation adverse effects, depression in children and adolescents
Acutely disturbed/violent behaviour Acutely disturbed or violent behaviour parenteral treatment zuclopenthixol acetate oral/inhaled treatment practical measures
Adapted Naranjo adverse drug reaction (ADR) probability scale criteria
Adherence
Administration of medicines covertly in food and drink, older people 629, alternative routes site of intramuscular injections
Adolescents adrenergic a2 agonists, tics and Tourette's syndrome bulimia nervosa/binge eating disorder
Adrenergic a2 agonists
Adverse and beneficial psychiatric side effects of antiseizure medications
Adverse effects
Age effects depression in children and adolescents changes in pharmacodynamics
Aggressive behaviours valproate treatment paradoxical/disinhibitory drug reactions, benzodiazepines
Agomelatine smokers in overdose
Agranulocytosis Biochemical and haematological effects of psychotropics Clozapine: serious haematological adverse effects Genetic testing for clozapine treatment Clozapine, neutropenia and lithium Clozapine: uncommon or unusual adverse effects
Akathisia Extrapyramidal symptoms Akathisia Relative adverse effects - a rough guide
Albumin hepatic impairment psychotropic agent effects
alcohol dehydrogenase (ADH) 895
Alcohol use amnesia bariatric surgery effects driving impairment health guidance pharmacodynamic interactions psychotropic drug combination ataxia disulfiram reaction electrolyte disturbances metabolism of pharmacokinetic interactions sedation
alcohol use disorder (AUD)
Alcohol withdrawal Alcohol dependence common interventions delirium tremens pharmacologically assisted detoxification severe treating somatic symptoms benzodiazepines community detoxification mild seizures severity assessment treatment interventions
Alcohol withdrawal treatment interventions - a summary
Algorithm for treating catatonic stupor.
5A-reductase inhibitors, psychiatric adverse effects
Abnormal Involuntary Movement Scale
Acamprosate, preventing relapse after alcohol detoxification